The mutual effect of progesterone and vitamin D in an animal model of peripheral nerve injury

Sedighe Nasirzadeh , Gholam Ali Hamidi, Hamid Reza Banafshe, Monireh Naderi Tehrani, Mohammad Shabani, Alireza Abed

Abstract


Background and purpose: Experimental and clinical studies have shown the potential role of progesterone in relieving neural injury. In addition, emerging data on vitamin D, a steroid hormone, have shown its neuroprotective properties. This study was designed to evaluate the mutual effect of vitamin D and progesterone on neuropathic pain (NP) in male rats.

Experimental approach: Chronic constriction injury (CCI) was induced by inserting four ligatures around the sciatic nerve. Hyperalgesia and allodynia (cold and mechanical) were considered positive behavioral scores of NP. After surgery, Sprague Dawley male rats (weighing 200-250 g) were assigned into 7 groups.                       Vitamin D (250 and 500 units/kg/day, i.p.) and progesterone (4 and 6 mg/kg/day, i.p.) were injected from the 1st day after CCI which continued for 21 days. Moreover, one group received the co-administration of vitamin D (500 units/kg/day, i.p.) and progesterone (6 mg/kg/day, i.p.) from the 1st day until the 21st post-CCI day. Behavioral tests were performed on the 7th, 14th, and 21st days.

Findings/Results: Daily supplementation with vitamin D (250 and 500 units/kg) did not alter nociception. Progesterone (4 and 6 mg/kg/day) was ineffective on thermal hyperalgesia. In the allodynia test, progesterone significantly decreased pain-related behaviors. The co-administration of vitamin D (500 units/kg/day) with progesterone (6 mg/kg/day) significantly relieved thermal hyperalgesia. Finally, the combination significantly decreased cold and mechanical allodynia.

Conclusion and implications: This study showed the mutual effect of progesterone and vitamin D on NP for the first time. Hyperalgesia and allodynia were significantly relieved following co-administration of vitamin D and progesterone.


Keywords


Allodynia; Hyperalgesia; Neuropathic pain; Progesterone; Vitamin D.

Full Text:

PDF

References


Meyers EC, Kasliwal N, Solorzano BR, Lai E, Bendale G, Berry A, et al. Enhancing plasticity in central networks improves motor and sensory recovery after nerve damage. Nat Commun. 2019;10(1):5782,1-14. DOI: 10.1038/s41467-019-13695-0.

Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019;160(1):53-59. DOI: 10.1097/j.pain.0000000000001365.

Watson JC, Dyck PJB. Peripheral neuropathy: a practical approach to diagnosis and symptom management. Mayo Clin Proc. 2015;90(7):940-951.DOI: 10.1016/j.mayocp.2015.05.004.

Silver S, Ledford CC, Vogel KJ, Arnold JJ. Peripheral nerve entrapment and injury in the upper extremity. Am Fam Physician. 2021;103(5):275-285.PMID: 33630556.

Nalamachu S. An overview of pain management: the clinical efficacy and value of treatment. Am J Manag Care. 2013;19(14 Suppl):s261-266. PMID: 24494608.

Roglio I, Giatti S, Pesaresi M, Bianchi R, Cavaletti G, Lauria G, et al. Neuroactive steroids and peripheral neuropathy. Brain Res Rev. 2008; 57(2):460-469.DOI: 10.1016/j.brainresrev.2007.04.010.

Melcangi RC, Garcia-Segura LM. Sex-specific therapeutic strategies based on neuroactive steroids: in search for innovative tools for neuroprotection. Horm Behav. 2010;57(1):2-11.DOI: 10.1016/j.yhbeh.2009.06.001.

Melcangi RC, Garcia-Segura LM. Therapeutic approaches to peripheral neuropathy based on neuroactive steroids. Expert Rev Neurother. 2006;6(8):1121-1125.DOI: 10.1586/14737175.6.8.1121.

Deli T, Orosz M, Jakab A. Hormone replacement therapy in cancer survivors - review of the literature. Pathol Oncol Res. 2020;26(1):63-78.DOI: 10.1007/s12253-018-00569-x.

Melcangi RC, Azcoitia I, Ballabio M, Cavarretta I, Gonzalez LC, Leonelli E, et al. Neuroactive steroids influence peripheral myelination: a promising opportunity for preventing or treating age-dependent dysfunctions of peripheral nerves. Prog Neurobiol. 2003;71(1):57-66.DOI: 10.1016/j.pneurobio.2003.09.003.

Roglio I, Bianchi R, Gotti S, Scurati S, Giatti S, Pesaresi M, et al. Neuroprotective effects of dihydroprogesterone and progesterone in an experimental model of nerve crush injury. Neuroscience. 2008; 155(3):673-685.DOI: 10.1016/j.neuroscience.2008.06.034.

He J, Evans CO, Hoffman SW, Oyesiku NM, Stein DG. Progesterone and allopregnanolone reduce inflammatory cytokines after traumatic brain injury. Exp Neurol. 2004;189(2):404-412.DOI: 10.1016/j.expneurol.2004.06.008.

Nematipour S, Vahidinia Z, Nejati M, Naderian H, Beyer C, Azami Tameh A. Estrogen and progesterone attenuate glutamate neurotoxicity via regulation of EAAT3 and GLT-1 in a rat model of ischemic stroke. Iran J Basic Med Sci. 2020;23(10):1346-1352.DOI: 10.22038/ijbms.2020.48090.11039.

Belelli D, Casula A, Ling A, Lambert JJ. The influence of subunit composition on the interaction of neurosteroids with GABA(A) receptors. Neuropharmacology. 2002;43(4):651-661. DOI: 10.1016/s0028-3908(02)00172-7.

Ciriza I, Azcoitia I, Garcia-Segura LM. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J Neuroendocrinol. 2004;16(1):58-63.DOI: 10.1111/j.1365-2826.2004.01121.x.

Cervantes M, González-Vidal MD, Ruelas R, Escobar A, Moralí G. Neuroprotective effects of progesterone on damage elicited by acute global cerebral ischemia in neurons of the caudate nucleus. Arch Med Res. 2002;33(1):6-14.DOI: 10.1016/s0188-4409(01)00347-2.

Harms LR, Burne THJ, Eyles DW, McGrath JJ. Vitamin D and the brain. Best Pract Res Clin Endocrinol Metab. 2011;25(4):657-669. DOI: 10.1016/j.beem.2011.05.009.

Cai Q, Tapper DN, Gilmour Jr RF, deTalamoni N, Aloia RC, Wasserman RH. Modulation of the excitability of avian peripheral nerves by vitamin D: relation to calbindin-D28k, calcium status and lipid composition. Cell Calcium. 1994;15(5):401-410.DOI: 10.1016/0143-4160(94)90015-9.

Hong SH, Lee JE, Kim HS, Jung YJ, Hwang D, Lee JH, et al. Effect of vitamin D3 on production of progesterone in porcine granulosa cells by regulation of steroidogenic enzymes. J Biomed Res. 2016;30(3):203-238.DOI: 10.7555/JBR.30.2016K0012.

Wang Y, Chiang YH, Su TP, Hayashi T, Morales M, Hoffer BJ, et al. Vitamin D(3) attenuates cortical infarction induced by middle cerebral arterial ligation in rats. Neuropharmacology. 2000;39(5):873-880. DOI: 10.1016/s0028-3908(99)00255-5.

Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904(1):67-75.DOI: 10.1016/s0006-8993(01)02450-7.

Garcion E, Sindji L, Montero-Menei C, Andre C, Brachet P, Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia. 1998;22(3):282-294.PMID: 9482214.

Ao T, Kikuta J, Ishii M. The effects of vitamin D on immune system and inflammatory diseases. Biomolecules. 2021;11(11):1624,1-9.DOI: 10.3390/biom11111624.

Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 Suppl):1678S-1688S. DOI: 10.1093/ajcn/80.6.1678S.

Aminmansour B, Asnaashari A, Rezvani M, Ghaffarpasand F, Noorian SMA, Saboori M, et al. Effects of progesterone and vitamin D on outcome of patients with acute traumatic spinal cord injury; a randomized, double-blind, placebo controlled study. J Spinal Cord Med. 2016;39(3):272-280. DOI: 10.1080/10790268.2015.1114224.

Cekic M, Sayeed I, Stein DG. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front Neuroendocrinol. 2009;30(2):158-172. DOI: 10.1016/j.yfrne.2009.04.002.

Banafshe HR, Khoshnoud MJ, Abed A, Saghazadeh M, Mesdaghinia A. Vitamin D supplementation attenuates the behavioral scores of neuropathic pain in rats. Nutr Neurosci. 2019;22(10):700-705.DOI: 10.1080/1028415X.2018.1435485.

Verdi J, Jafari-Sabet M, Mokhtari R, Mesdaghinia A, Banafshe HR. The effect of progesterone on expression and development of neuropathic pain in a rat model of peripheral neuropathy. Eur J Pharmacol. 2013;699(1-3):207-212. DOI: 10.1016/j.ejphar.2012.11.052.

Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 1998;33(1):87-107.DOI: 10.1016/0304-3959(88)90209-6.

Abed A, Hajhashemi V, Banafshe HR, Minaiyan M, Mesdaghinia A. Venlafaxine attenuates heat hyperalgesia independent of adenosine or opioid system in a rat model of peripheral neuropathy. Iran J Pharm Res. 2015;14(3):843-850.PMID: 26330872.

Abed A, Khoshnoud MJ, Taghian M, Aliasgharzadeh M, Mesdaghinia A. Quetiapine reverses paclitaxel-induced neuropathic pain in mice: role of alpha2- adrenergic receptors. Iran J Basic Med Sci. 2017;20(11):1182-1188.DOI: 10.22038/IJBMS.2017.9500.

Talaei SA, Banafshe HR, Moravveji A, Shabani M, Tehrani SS, Abed A. Anti-nociceptive effect of black seed oil on an animal model of chronic constriction injury. Res Pharm Sci. 2022;17(4):383-391.DOI: 10.4103/1735-5362.350239.

Abed AR, Abed A, Banafshe HR, Malekabad ES, Gorgani-Firuzjaee S, Dadashi AR. Effect of biotin supplementation on neuropathic pain induced by chronic constriction of the sciatic nerve in the rat. Res Pharm Sci. 2021;16(3):250-259.DOI: 10.4103/1735-5362.314823.

Banafshe HR, Hajhashemi V, Minaiyan M, Mesdaghinia A, Abed A. Antinociceptive effects of maprotiline in a rat model of peripheral neuropathic pain: possible involvement of opioid system. Iran J Basic Med Sci. 2015;18(8):752-757.PMID: 26557963.

Abboud C, Duveau A, Bouali-Benazzouz R, Massé K, Mattar J, Brochoire L, et al. Animal models of pain: diversity and benefits. J Neurosci Methods. 2021;348:108997,1-79. DOI: 10.1016/j.jneumeth.2020.108997.

Amin B, Hajhashemi V, Hosseinzadeh H. Minocycline potentiates the anti-hyperalgesic effect of ceftriaxone in CCI-induced neuropathic pain in rats. Res Pharm Sci. 2015;10(1):34-42.PMID: 26430455.

Maier C, Baron R, Tölle TR, Binder A, Birbaumer N, Birklein F, et al. Quantitative sensory testing in the German research network on neuropathic pain (DFNS): somatosensory abnormalities in 1236 patients with different neuropathic pain syndromes. Pain. 2010;150(3):439-450.DOI: 10.1016/j.pain.2010.05.002.

Ossipov MH, Lai J, Malan Jr TP, Porreca F. Spinal and supraspinal mechanisms of neuropathic pain. Ann N Y Acad Sci. 2000;909:12-24.DOI: 10.1111/j.1749-6632.2000.tb06673.x.

Habig K, Schänzer A, Schirner W, Lautenschläger G, Dassinger B, Olausson H, et al. Low threshold unmyelinated mechanoafferents can modulate pain. BMC Neurol. 2017;17(1):184,1-11.DOI: 10.1186/s12883-017-0963-6.

Stein DG, Wright DW, Kellermann AL. Does progesterone have neuroprotective properties? Ann Emerg Med. 2008;51(2):164-172. DOI: 10.1016/j.annemergmed.2007.05.001.

Labombarda F, Deniselle MCG, De Nicola AF, González SL. Progesterone and the spinal cord: good friends in bad times. Neuroimmunomodulation. 2010;17(3):146-149.DOI: 10.1159/000258709.

Baulieu EE, Schumacher M, Koenig H, Jung-Testas I, Akwa Y. Progesterone as a neurosteroid: actions within the nervous system. Cell Mol Neurobiol. 1996;16(2):143-154. DOI: 10.1007/BF02088173.

Wei J, Xiao GM. The neuroprotective effects of progesterone on traumatic brain injury: current status and future prospects. Acta Pharmacol Sin. 2013;34(12):1485-1490.DOI: 10.1038/aps.2013.160.

Roof RL, Hoffman SW, Stein DG. Progesterone protects against lipid peroxidation following traumatic brain injury in rats. Mol Chem Neuropathol. 1997;31(1):1-11.DOI: 10.1007/BF02815156.

Wang M. Neurosteroids and GABA-A receptor function. Front Endocrinol (Lausanne). 2011; 2:44,1-28.DOI: 10.3389/fendo.2011.00044.

Meyer L, Patte-Mensah C, Taleb O, Mensah-Nyagan AG. Allopregnanolone prevents and suppresses oxaliplatin-evoked painful neuropathy: multi-parametric assessment and direct evidence. Pain. 2011;152(1):170-181.DOI: 10.1016/j.pain.2010.10.015.

Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a neuroactive substance: review. ScientificWorldJournal. 2006;6:125-139. DOI: 10.1100/tsw.2006.25.

Carver CM, Reddy DS. Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability. Psychopharmacology (Berl). 2013;230(2):151-188.DOI: 10.1007/s00213-013-3276-5.

Gezen-Ak D, Dursun E, Yilmazer S. The effect of vitamin D treatment on nerve growth factor (NGF) release from hippocampal neurons. Noro Psikiyatr Ars. 2014;51(2):157-162. DOI: 10.4274/npa.y7076.

Khairy EY, Attia MM. Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF). Nutr Neurosci. 2021;24(8):650-659. DOI: 10.1080/1028415X.2019.1665854.

Shipton EA, Shipton EE. Vitamin D and pain: vitamin D and its role in the aetiology and maintenance of chronic pain states and associated comorbidities. Pain Res Treat. 2015;2015:904967, 1-12.DOI: 10.1155/2015/904967.

Kolcsár M, Berecki B, Gáll Z. Relationship between serum 25-hydroxyvitamin D levels and hormonal status in infertile women: a retrospective study. Diagnostics (Basel). 2023;13(19):3024,1-12. DOI: 10.3390/diagnostics13193024.

Cornet A, Baudet C, Neveu I, Evercooren ABV, Brachet P, Naveilhan P. 1,25-Dihydroxyvitamin D3 regulates the expression of VDR and NGF gene in schwann cells in vitro. J Neurosci Res. 1998;53(6):742-746.DOI: 10.1002/(SICI)1097.

Monastra G, De Grazia S, De Luca L, Vittorio S, Unfer V. Vitamin D: a steroid hormone with progesterone-like activity. Eur Rev Med Pharmacol Sci. 2018;22(8):2502-2512. DOI: 10.26355/eurrev_201804_14845.

Atif F, Yousuf S, Sayeed I, Ishrat T, Hua F, Stein DG. Combination treatment with progesterone and vitamin D hormone is more effective than monotherapy in ischemic stroke: the role of BDNF/TrkB/Erk1/2 signaling in neuroprotection. Neuropharmacology. 2013;67:78-87.DOI: 10.1016/j.neuropharm.2012.10.004.

Hua F, Reiss JI, Tang H, Wang J, Fowler X, Sayeed I, et al. Progesterone and low-dose vitamin D hormone treatment enhances sparing of memory following traumatic brain injury. Horm Behav. 2012;61(4):642-651.DOI: 10.1016/j.yhbeh.2012.02.017.

Sayeed I, Parvez S, Wali B, Siemen D, Stein DG. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism for better neuroprotective effects of allopregnanolone over progesterone. Brain Res. 2009;1263:165-173.DOI: 10.1016/j.brainres.2009.01.045.

Chabas JF, Alluin O, Rao G, Garcia S, Lavaut MN, Risso JJ, et al. Vitamin D2 potentiates axon regeneration. J Neurotrauma. 2008;25(10): 1247-1256.DOI: 10.1089/neu.2008.0593.

El-Etr M, Rame M, Boucher C, Ghoumari AM, Kumar N, Liere P, et al. Progesterone and nestorone promote myelin regeneration in chronic demyelinating lesions of corpus callosum and cerebral cortex. Glia. 2015;63(1):104-117.DOI: 10.1002/glia.22736.


Refbacks

  • There are currently no refbacks.


Creative Commons LicenseThis work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.